Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Magnesium Sulphate as Adjuvants With Bupivacaine in ESPB for Post Thoracotomy Pain
NCT05851768Recruiting
- Sponsor
- National Cancer Institute
- Start
- May 2023
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine and magnesium sulfate in postoperative pain (3 arms), sponsored by National Cancer Institute. Primary endpoint: Total postoperative morphine consumption at 24 hours. Started May 2023; status: recruiting.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05851768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05851768.